Researchers discovered a molecular link between exercise, dietary timing and liver protection against metabolic dysfunction-associated steatotic liver disease (MASLD). The study found that exercise and time-restricted feeding suppress a specific signaling axis involving miR-802, PPARγ and Psmd2.
A study found that a TERT genetic variant may reduce the risk of developing cholangiocarcinoma, but be associated with worse outcomes in cancer patients. The variant was linked to improved overall survival rates before diagnosis, but poorer survival rates after diagnosis.
Researchers redefine steatotic liver disease as a dynamic trajectory, highlighting the need for longitudinal assessment of alcohol intake and metabolic risk factors. The proposed framework integrates objective biomarkers like phosphatidylethanol to improve diagnosis and treatment.
The platform enables simultaneous visualization of multiple hepatic cell populations, including hepatocytes, cholangiocytes, macrophages, endothelial cells and hepatic stellate cells. It also extends multiplex imaging beyond tissue sections to organoids, primary liver cell cultures and advanced liver-on-a-chip platforms.
New research suggests that megamitochondria initially protect hepatocytes during early alcohol exposure, but later contribute to inflammation and liver cancer progression. The study proposes a 'dual-phase' model, highlighting the importance of mitochondrial dynamics in regulating metabolism and innate immunity.
Researchers developed an optimized extended precision cut liver slice (PCLS) culture system maintaining viable human liver tissue for up to two weeks. The model captures regeneration, fibrosis, and biliary remodeling in intact human liver tissue.
Acute liver failure is driven by massive hepatic necrosis, a catastrophic form of liver injury characterized by extensive hepatocyte loss. Liver progenitor cells play a key role in regeneration and functional compensation, enabling patients to survive despite severe liver damage.
Researchers developed a machine learning-based approach to accelerate therapeutic discovery for ulcerative colitis. The model identified 22 promising antimicrobial peptides, one of which, LR, showed strong antibacterial activity and low cytotoxicity.
This study reveals that p62-dependent protein aggregates protect liver cells against severe alcohol damage, providing a new perspective on toxic protein accumulation. The researchers found that the formation of these aggregates is not harmful but rather an adaptive response to chronic alcohol stress.
A new category of liver disease, MetALD, combines metabolic dysfunction and alcohol-related liver injury, representing a spectrum between metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. MetALD management requires simultaneous control of metabolic risk factors and alcohol use.
A study published in eGastroenterology reveals that Autophagy Related 14 (ATG14) plays a critical role in protecting the liver against injury and fibrosis. ATG14 deficiency leads to severe hepatocellular injury, oxidative stress, and inflammation, highlighting its importance in maintaining hepatocyte homeostasis.
Researchers developed mRNA-encoded nanobodies to combat colorectal cancer, offering new hope for patients resistant to conventional immunotherapies. The treatment demonstrated superior efficacy against sporadic and colitis-associated colorectal cancer.
Researchers found UDCA activates ileal FXR signaling, not antagonism, and has sex-specific effects on BA metabolism. In male mice, UDCA reduces steatosis, liver injury markers, and fibrosis, while in females, it increases T-MCAs, potent FXR antagonists.
Colectomy and liver transplantation alter disease behavior in IBD-Associated PSC, highlighting unique risks and challenges. PSC patients face heightened cancer risk after colectomy, while transplant reshapes risks of de novo IBD and recurrent PSC.
This study reveals significant viral-host interactions in colorectal polyps, identifying specific viruses associated with oncogenic and tumor-suppressive transcriptomic profiles. The findings suggest that viral activity contributes to early neoplastic transformation, challenging the traditional view of viruses as mere bystanders.
Steatotic liver disease, caused by metabolic dysfunction-associated steatosis, alcohol-related liver disease, and more, affects over 30% of adults worldwide. Emerging genetic variants like PNPLA3, TM6SF2, and MBOAT7 modulate susceptibility to SLD, which progresses to cancer through cumulative genomic instability and immune dysregulation.
A new study links gut dysbiosis to severe steatosis in MASLD, improving diagnostic accuracy when microbiota status is added to standard clinical tools. The inflammation-linked Bact2 enterotype is strongly associated with severe hepatic steatosis in MASLD.
A blood test using microbial DNA analysis can distinguish primary liver cancer from colorectal cancer that has spread to the liver, according to a new study. The test reveals distinct bacterial 'fingerprints' for each cancer type, making it a powerful tool for non-invasive diagnosis and potential future therapy guidance.
Researchers used single-cell transcriptomics to study liver injury and repair. They found that hepatocytes can migrate to damaged areas, and that hepatic stellate cells play a dual role in contributing to fibrosis and supporting regeneration. Endothelial cells regulate regenerative signaling, and macrophages exhibit heterogeneity durin...
Researchers found that patients carrying colibactin-producing Escherichia coli in their colon polyps were more than three times as likely to have a history of colorectal cancer compared to those without the bacterium. The study suggests that targeting specific microbes could help prevent cancer in high-risk groups.
Transthyretin amyloidosis has transitioned from a fatal underdiagnosed disease to one with multiple effective treatment avenues, including gene editing and targeted therapies that have shown significant improvements in neuropathy scores and quality of life. Ongoing clinical trials aim to halt and potentially reverse disease progression.
A recent meta-analysis found that Helicobacter pylori eradication may be associated with an increased risk of developing or experiencing reflux oesophagitis. The study analyzed data from 30 studies and showed a statistically significant increase in RE risk in RCTs, but not in cohort studies. Age, underlying diseases, region, and durati...
The new guidelines introduce a pivotal terminology shift, replacing NAFLD with MASLD and NASH with MASH. MASLD is now grouped under the umbrella of "steatotic liver disease" (SLD), along with alcohol-associated liver disease (ALD) and other causes.
A 21-day study found that restricting food variety triggers unique shifts in individual gut microbiomes, contradicting the assumption of uniform microbial outcomes. The results suggest personalized nutrition approaches are essential for achieving targeted microbiome modulation.
This study identifies ANXA2+ migratory hepatocytes as crucial for liver regeneration, highlighting their role in promoting wound closure and treating acute liver failure. The research also explores the therapeutic potential of targeting these cells, offering new avenues for regenerative medicine approaches in hepatology.
A recent national study reveals complex patterns of burden and survival trends for digestive system malignancies (DSMTs) in China. Despite progress in reducing mortality from some cancers, the overall impact remains significant, with notable disparities across demographic and geographic lines.
Research highlights the critical role of epigenetic changes in hepatocellular carcinoma development, including DNA methylation and histone modifications. Noncoding RNAs also play a key role in HCC pathogenesis and may serve as biomarkers for diagnosis and prognosis.
A global study found that pentoxifylline has no mortality benefit in patients with severe alcohol-associated hepatitis and acute kidney injury. The study, which included 525 patients across 20 centers from eight countries, reaffirmed previous findings that cast doubt on the efficacy of pentoxifylline in alcoholic hepatitis.
A new study finds that macrophages, the liver's cleanup specialists, quickly adapt after injury to clear debris and support tissue recovery. The research highlights the dynamic nature of these cells during liver injury and repair, offering promising implications for future therapies.
Researchers found major disruptions in the gut microbiome after alcohol and burn injury, with beneficial microbes depleted and harmful species surging. The study suggests replenishing lost microbial metabolites could help protect the gut and body after trauma.
The study found that fecal microbiota transplantation (FMT) can outcompete H. pylori, producing antimicrobial peptides and metabolic byproducts to create a hostile environment. FMT may also mitigate adverse effects of antibiotic treatments, improving patient tolerance.
A new review suggests a strong association between gum disease and chronic liver conditions, including cirrhosis and metabolic dysfunction. The 'oral-gut-liver axis' theory proposes that pathogenic bacteria from the mouth can exacerbate liver inflammation and fibrosis through dysbiosis and increased gut permeability.
Scientists discover blocking gasdermin D, a key inflammatory protein, improves liver health while damaging kidneys and brain in severe liver disease patients. The study's findings suggest that future therapies may need to target this pathway in a more nuanced way.
A recent study found that the protein tyrosine phosphatase delta (PTPRD) acts as a suppressor of the pro-inflammatory STAT3 pathway in liver cells, regulating lipid and glucose metabolism and protecting peroxisomal function. Reduced PTPRD expression was associated with signs of liver dysfunction and metabolic syndrome in humans.
A new study reveals that inhibiting gut cannabinoid receptor 1 (CB1R) can help protect the gut barrier and prevent alcohol-induced intestinal permeability. By targeting CB1R, researchers hope to develop a novel therapeutic approach for treating alcohol-related digestive disorders.
Recent research challenges the traditional distinction between functional dyspepsia (FD) and gastroparesis (GP), suggesting they represent a continuum of the same disease. The review highlights significant symptom overlap, shared pathophysiological mechanisms, and potential therapeutic strategies.
Long non-coding RNAs (lncRNAs) play a critical role in metabolic and fibrotic pathways, influencing lipid metabolism, inflammation, apoptosis, and fibrogenesis. Targeting pathogenic lncRNAs or enhancing protective ones may provide a dual approach for MASLD treatment.
The unfolded protein response (UPR) is a critical regulator of intestinal epithelial cell function, and its disruption contributes to inflammatory bowel diseases and colorectal cancer. X-box binding protein 1 (XBP1) plays a crucial role in maintaining IEC function.
Researchers have developed a rabbit model to study CF-related pancreatic endocrine pathology, offering new insights into the disease's pathophysiology. The model identifies an indeterminate glucose tolerance stage in young CF rabbits, mirroring early signs of diabetes progression in humans.
IL-8+ neutrophils are central drivers of inflammation in alcohol-associated hepatitis, and targeting them may lead to selective reduction of inflammation. Several strategies for targeting IL-8 signaling have been proposed, including therapeutic antibodies and inhibitors.
Researchers developed a prediction model for infected pancreatic necrosis (IPN) in acute pancreatitis patients, identifying high-risk individuals within 24 hours of hospital admission. The model achieved an area under the receiver operating characteristic curve (AUC) of 0.85, outperforming widely used scoring systems.
The review summarizes findings on cellular, molecular, and systemic processes involved in ALD progression, highlighting pathways for future research. It also discusses the role of extracellular vesicles in intercellular communication and their implications for early diagnosis and therapeutic intervention.
A new prognostic model, the CATCH-LIFE-MELD score, has been developed to predict short-term survival outcomes in patients with acute-on-chronic liver failure. The model's enhanced accuracy allows clinicians to identify high-risk patients who may benefit from urgent interventions, such as liver transplantation.
Recent studies have demonstrated a causal role for the gut microbiome in multiple diseases, including gastrointestinal conditions and immune-related disorders. Manipulating the gut microbiome may open new avenues for treatment, such as fecal microbiota transplantation (FMT) showing efficacy in reducing CDI recurrence rates up to 93%.
Researchers found that lysosomal stress can disrupt normal pancreatic function, leading to impaired insulin production and glucose regulation in various diabetes types. Targeting lysosomal function may lead to new treatments for diabetes.
Researchers have discovered that goblet cells act as dynamic guardians of gut immunity, engaging in multiple protective actions beyond pathogen defense. They produce specialized structures called GAPs, which enable immune cells to access gut contents while maintaining tolerance and preventing immunogenic responses.
Researchers highlight liquid biopsy as a promising tool for detecting pancreatic incidentaloma and its potential to catch lesions early, thereby improving patient outcomes. The study also emphasizes the importance of clear guidelines for addressing incidental findings while balancing diagnostic utility with patient well-being.
Advanced endoscopy combined with AI and digital pathology offers a deeper understanding of inflammatory bowel diseases (IBD). This leads to more accurate diagnoses and improved patient outcomes.
Researchers used spatial transcriptomics to analyze liver biopsies from patients with CHB, uncovering distinct gene expression signatures and unique immune cell compositions. The study sheds light on the intricate interplay between the virus and the immune system, paving the way for developing novel therapeutic strategies.
Researchers used Mendelian randomization to identify lifestyle factors, circulating nutrients, and obesity as risk factors for various intestinal diseases. The study suggests that modifying lifestyle habits and optimizing diet can reduce the risk of bowel disease.